Skip to main content

Grygiel Nancy A.'s Form 4 filing

Amgen Inc (AMGN) · filed Nov 8, 2022

Accession no.
0001127602-22-025154
Filed
Nov 8, 2022
Trade date
Nov 5-8, 2022
Filing delay
3 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $160.0K. It was filed 3 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Grygiel Nancy A.CIK 0001816414Officer (SVP & CCO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 5, 2022Common StockFTax withholdingDisposed−240$269.04−$64,569.613,554Direct
Nov 8, 2022Common StockSSaleDisposed−545$293.54−$159,979.313,009Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)